We are live on
!
Find out more
CCM
Callodine Capital Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
8.74%
This Fund
S&P 500
This Quarter
Est. Return
-0.4%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$20.4M
(+8.9%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
11.1%
Top 10 Holdings %
Top 10 Hldgs %
64.01%
Holding
39
New
7
Increased
16
Reduced
8
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$11.5M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$10.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$9.87M |
| 4 |
Verizon
VZ
|
+$9.36M |
| 5 |
Molson Coors Class B
TAP
|
+$8.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$15.7M |
| 2 |
Kinder Morgan
KMI
|
+$9.24M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$4.95M |
| 4 |
FedEx
FDX
|
+$4.81M |
| 5 |
MidCap Financial Investment
MFIC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.81% |
| 2 | Communication Services | 19.36% |
| 3 | Healthcare | 14.25% |
| 4 | Real Estate | 11.28% |
| 5 | Consumer Staples | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Energy Transfer Partners
ET
$70B
| $2.03M | 0.81% |
155,000
+25,000
| +19% | +$349K |
|
27
Crown Castle
CCI
$32.3B
| $1.74M | 0.7% |
+12,500
| New | +$1.73M |
|
28
Blackstone
BX
$109B
| $1.22M | 0.49% |
+25,000
| New | +$1.22M |
|
|
NSLR
29
Neostellar Capital Corp
NSLR
$289M
| $1.06M | 0.42% |
202,517
-2,264
| -1% | -$12.2K |
|
30
Acacia Research
ACTG
$439M
| $831K | 0.33% |
310,000
+160,000
| +107% | +$447K |
|
31
Oxford Square Capital
OXSQ
$158M
| $312K | 0.12% |
50,000
| – | – |
|
32
Equus Total Return
EQS
$16.5M
| $45K | 0.02% |
+27,748
| New | +$45.8K |
|
33
Ares Management
ARES
$31.5B
| – | – |
-150,000
| Closed | -$3.93M |
|
|
34
FedEx
FDX
$73.5B
| – | – |
-29,275
| Closed | -$4.81M |
|
35
GE Aerospace
GE
$396B
| – | – |
-55,175
| Closed | -$2.89M |
|
36
Investcorp Credit Management BDC
ICMB
$11.9M
| – | – |
-40,280
| Closed | -$304K |
|
|
37
Kinder Morgan
KMI
$69.3B
| – | – |
-442,767
| Closed | -$9.24M |
|
|
38
MidCap Financial Investment
MFIC
$781M
| – | – |
-269,815
| Closed | -$4.26M |
|
39
Toll Brothers
TOL
$14.5B
| – | – |
-60,480
| Closed | -$2.21M |
|
Similar funds
TS
SCA
SC
KPF
KGI
WIM
APCM
KCMH
Callodine Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Callodine Capital Management held 39 positions worth $250M, up 8.9% from $230M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Callodine Capital Management deployed $27.7M of net new capital in Q3 2019, opening 7 new positions and adding to 16 existing holdings. Its largest new stake was Altria Group: 250,000 shares worth $10.2M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Allergan plc, an estimated $15.7M trimmed.
- Callodine Capital Management's largest Q3 2019 buy was Altria Group: 250,000 shares worth $10.2M.
- Callodine Capital Management added most to Bristol-Myers Squibb in Q3 2019, an estimated $9.87M increase.
- Callodine Capital Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $15.7M.
- Callodine Capital Management fully exited Kinder Morgan in Q3 2019, selling an estimated $9.24M.
- Callodine Capital Management's ten largest holdings make up 64% of its $250M portfolio in Q3 2019.
- Callodine Capital Management opened 7 new positions and closed 7 in Q3 2019.
- Callodine Capital Management's portfolio value rose 8.9% quarter-over-quarter to $250M.
Based on Callodine Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.